Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.

Berntorp, Erik LU ; Negrier, C ; Gozzi, P ; Blaas, P-M and Lethagen, S (2016) In Haemophilia
Abstract
To use Pharmacokinetic (PK) simulations to illustrate potential differences in clinical outcomes between prophylaxis with conventional recombinant factor VIII (rFVIII) and rFVIIIFc, an extended half-life rFVIII covalently fused to the Fc domain of human IgG1.
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Haemophilia
publisher
Wiley-Blackwell
external identifiers
  • pmid:26863900
  • scopus:84958279902
  • pmid:26863900
  • wos:000379715000035
ISSN
1351-8216
DOI
10.1111/hae.12887
language
English
LU publication?
yes
id
7bf7d164-1e29-4fee-8a80-c0d312ba47d7 (old id 8825865)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26863900?dopt=Abstract
date added to LUP
2016-04-04 07:22:40
date last changed
2022-08-23 02:43:34
@article{7bf7d164-1e29-4fee-8a80-c0d312ba47d7,
  abstract     = {{To use Pharmacokinetic (PK) simulations to illustrate potential differences in clinical outcomes between prophylaxis with conventional recombinant factor VIII (rFVIII) and rFVIIIFc, an extended half-life rFVIII covalently fused to the Fc domain of human IgG1.}},
  author       = {{Berntorp, Erik and Negrier, C and Gozzi, P and Blaas, P-M and Lethagen, S}},
  issn         = {{1351-8216}},
  language     = {{eng}},
  month        = {{02}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{Haemophilia}},
  title        = {{Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.}},
  url          = {{http://dx.doi.org/10.1111/hae.12887}},
  doi          = {{10.1111/hae.12887}},
  year         = {{2016}},
}